Literature DB >> 24926618

Nemo-like kinase is critical for p53 stabilization and function in response to DNA damage.

H-H Zhang1, S-Z Li1, Z-Y Zhang1, X-M Hu1, P-N Hou1, L Gao2, R-L Du1, X-D Zhang1.   

Abstract

The DNA damage response (DDR) acts as a protective mechanism for maintaining cell homeostasis. Nemo-like kinase (NLK) is a serine/threonine-protein kinase that has an important role in many pathways; however, its function in the DDR has not yet been defined. In our study, NLK-deficient HCT116 cells were found to be resistant to etoposide-induced cell death. We demonstrated that NLK is required for p53 activation in response to DNA damage. Remarkably, mechanistic studies revealed that NLK interacts with p53 and stabilizes p53 by blocking MDM2-mediated p53 ubiquitination and degradation. Furthermore, NLK enhances p53 activity and affects expression downstream of p53. Interestingly, these functions of NLK are not related to its kinase activity. Consistent with these results, NLK-deficient cells have a resistance effect on DNA damage. Therefore, these findings emphasize that NLK is a novel factor in DDR mechanisms.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24926618      PMCID: PMC4158690          DOI: 10.1038/cdd.2014.78

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  36 in total

1.  Efficient gene targeting mediated by adeno-associated virus and DNA double-strand breaks.

Authors:  Matthew H Porteus; Toni Cathomen; Matthew D Weitzman; David Baltimore
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

Review 2.  Live or let die: the cell's response to p53.

Authors:  Karen H Vousden; Xin Lu
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

Review 3.  p53: a heavily dictated dictator of life and death.

Authors:  Xin Lu
Journal:  Curr Opin Genet Dev       Date:  2005-02       Impact factor: 5.578

Review 4.  Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation.

Authors:  Christopher L Brooks; Wei Gu
Journal:  Curr Opin Cell Biol       Date:  2003-04       Impact factor: 8.382

Review 5.  Etoposide: four decades of development of a topoisomerase II inhibitor.

Authors:  K R Hande
Journal:  Eur J Cancer       Date:  1998-09       Impact factor: 9.162

6.  SIKE is an IKK epsilon/TBK1-associated suppressor of TLR3- and virus-triggered IRF-3 activation pathways.

Authors:  Jun Huang; Ting Liu; Liang-Guo Xu; Danying Chen; Zhonghe Zhai; Hong-Bing Shu
Journal:  EMBO J       Date:  2005-11-10       Impact factor: 11.598

7.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.

Authors:  Jirina Bartkova; Zuzana Horejsí; Karen Koed; Alwin Krämer; Frederic Tort; Karsten Zieger; Per Guldberg; Maxwell Sehested; Jahn M Nesland; Claudia Lukas; Torben Ørntoft; Jiri Lukas; Jiri Bartek
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

Review 8.  Wild-type p53: tumors can't stand it.

Authors:  Michael B Kastan
Journal:  Cell       Date:  2007-03-09       Impact factor: 41.582

9.  Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T.

Authors:  Xiaodong Zhang; Ailan Guo; Jianshi Yu; Anthony Possemato; Yueting Chen; Weiping Zheng; Roberto D Polakiewicz; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu; Zhenghe John Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-21       Impact factor: 11.205

10.  Nemo-like kinase induces apoptosis in DLD-1 human colon cancer cells.

Authors:  Jun Yasuda; Akira Tsuchiya; Tesshi Yamada; Michiie Sakamoto; Takao Sekiya; Setsuo Hirohashi
Journal:  Biochem Biophys Res Commun       Date:  2003-08-22       Impact factor: 3.575

View more
  21 in total

1.  Integrin α5β1 and p53 convergent pathways in the control of anti-apoptotic proteins PEA-15 and survivin in high-grade glioma.

Authors:  G Renner; H Janouskova; F Noulet; V Koenig; E Guerin; S Bär; J Nuesch; F Rechenmacher; S Neubauer; H Kessler; A-F Blandin; L Choulier; N Etienne-Selloum; M Lehmann; I Lelong-Rebel; S Martin; M Dontenwill
Journal:  Cell Death Differ       Date:  2015-10-16       Impact factor: 15.828

2.  DUB3 deubiquitinates and stabilizes NRF2 in chemotherapy resistance of colorectal cancer.

Authors:  Qi Zhang; Ze-Yan Zhang; Huan Du; Shang-Ze Li; Rongfu Tu; Yi-Fan Jia; Zhe Zheng; Xue-Min Song; Run-Lei Du; Xiao-Dong Zhang
Journal:  Cell Death Differ       Date:  2019-02-18       Impact factor: 15.828

3.  Stabilization of ATF5 by TAK1-Nemo-like kinase critically regulates the interleukin-1β-stimulated C/EBP signaling pathway.

Authors:  Ze-Yan Zhang; Shang-Ze Li; Hui-Hui Zhang; Qu-Ran Wu; Jun Gong; Tong Liang; Lu Gao; Na-Na Xing; Wen-Bin Liu; Run-Lei Du; Xiao-Dong Zhang
Journal:  Mol Cell Biol       Date:  2014-12-15       Impact factor: 4.272

4.  Expression of Nemo-like kinase was increased and negatively correlated with the expression of TCF4 in lung cancers.

Authors:  Xiu-Wei Zhang; Song-Yan Chen; Dong-Wei Xue; Hui-Hui Xu; Lian-He Yang; Hong-Tao Xu; En-Hua Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

5.  The p53 tetramer shows an induced-fit interaction of the C-terminal domain with the DNA-binding domain.

Authors:  M D'Abramo; N Bešker; A Desideri; A J Levine; G Melino; G Chillemi
Journal:  Oncogene       Date:  2015-10-19       Impact factor: 9.867

Review 6.  Molecular mechanisms of etoposide.

Authors:  Alessandra Montecucco; Francesca Zanetta; Giuseppe Biamonti
Journal:  EXCLI J       Date:  2015-01-19       Impact factor: 4.068

Review 7.  P53 functional abnormality in mesenchymal stem cells promotes osteosarcoma development.

Authors:  T Velletri; N Xie; Y Wang; Y Huang; Q Yang; X Chen; Q Chen; P Shou; Y Gan; G Cao; G Melino; Y Shi
Journal:  Cell Death Dis       Date:  2016-01-21       Impact factor: 8.469

Review 8.  Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosis.

Authors:  S Nicolai; M Pieraccioli; A Peschiaroli; G Melino; G Raschellà
Journal:  Cell Death Dis       Date:  2015-12-03       Impact factor: 8.469

9.  p73 promotes glioblastoma cell invasion by directly activating POSTN (periostin) expression.

Authors:  Vivien Landré; Alexey Antonov; Richard Knight; Gerry Melino
Journal:  Oncotarget       Date:  2016-03-15

10.  Anti-tumoral effect of desmethylclomipramine in lung cancer stem cells.

Authors:  Lucilla Bongiorno-Borbone; Arianna Giacobbe; Mirco Compagnone; Adriana Eramo; Ruggero De Maria; Angelo Peschiaroli; Gerry Melino
Journal:  Oncotarget       Date:  2015-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.